PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29959872-0	2018	Flavin-Containing Monooxygenase 3 Polymorphic Variants Significantly Affect Clearance of Tamoxifen and Clomiphene.	Clomiphene	103-113	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	0-33	
29959872-3	2018	The purpose of this study was to investigate the effect of the three common polymorphic variants of hFMO3 (V257M, E158K and E308G) on the metabolism and clearance of three structurally similar compounds: tamoxifen (breast cancer medication), clomiphene (infertility medication) and GSK5182 (antidiabetic lead molecule).	Clomiphene	242-252	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	100-105	
32197603-3	2020	Here, Escherichia coli (E. coli) JM109 cells over-expressing the recombinant human FMO3 (flavin-containing monooxygenase isoform 3) were used for the conversions of clomiphene, dasatinib, GSK5182 and tozasertib to their corresponding N-oxide metabolites.	Clomiphene	165-175	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	83-87	
32197603-3	2020	Here, Escherichia coli (E. coli) JM109 cells over-expressing the recombinant human FMO3 (flavin-containing monooxygenase isoform 3) were used for the conversions of clomiphene, dasatinib, GSK5182 and tozasertib to their corresponding N-oxide metabolites.	Clomiphene	165-175	flavin containing dimethylaniline monoxygenase 3	Homo sapiens	89-130